PHIMC
VRTX icon

Private Harbour Investment Management & Counsel’s Vertex Pharmaceuticals VRTX Stock Holding History

Private Harbour Investment Management & Counsel’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.18M Buy
4,395
+12
+0.3% +$5.32K 2.59% 13
2026
Q1 		$1.96M Sell
4,383
-53
-1% -$24.7K 2.15% 17
2025
Q4 		$2.01M Sell
4,436
-13
-0.3% -$5.6K 2.1% 15
2025
Q3 		$1.74M Sell
4,449
-331
-7% -$138K 1.8% 20
2025
Q2 		$2.13M Sell
4,780
-45
-0.9% -$20.7K 2.2% 18
2025
Q1 		$2.34M Sell
4,825
-267
-5% -$124K 2.6% 16
2024
Q4 		$2.05M Sell
5,092
-221
-4% -$102K 2.25% 17
2024
Q3 		$2.47M Sell
5,313
-20
-0.4% -$9.61K 2.6% 15
2024
Q2 		$2.5M Sell
5,333
-70
-1% -$30.4K 2.63% 15
2024
Q1 		$2.26M Sell
5,403
-30
-0.6% -$12.7K 2.43% 16
2023
Q4 		$2.21M Sell
5,433
-118
-2% -$43.6K 2.54% 16
2023
Q3 		$1.93M Sell
5,551
-29
-0.5% -$10.1K 2.21% 17
2023
Q2 		$1.96M Sell
5,580
-86
-2% -$29K 2.2% 18
2023
Q1 		$1.79M Sell
5,666
-122
-2% -$36.6K 2.01% 20
2022
Q4 		$1.67M Hold
5,788
– – 1.84% 23
2022
Q3 		$1.68M Sell
5,788
-305
-5% -$87.8K 1.94% 18
2022
Q2 		$1.72M Sell
6,093
-76
-1% -$20.3K 1.9% 22
2022
Q1 		$1.61M Sell
6,169
-50
-0.8% -$11.9K 1.35% 30
2021
Q4 		$1.37M Sell
6,219
-15
-0.2% -$2.92K 1.09% 35
2021
Q3 		$1.13M Hold
6,234
– – 1% 37
2021
Q2 		$1.26M Sell
6,234
-237
-4% -$49.6K 1.1% 37
2021
Q1 		$1.39M Buy
+6,471
New +$1.42M 1.26% 37

Other funds holding VRTX

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Private Harbour Investment Management & Counsel's VRTX Position: Q2 2026 in Review

Private Harbour Investment Management & Counsel increased its Vertex Pharmaceuticals (VRTX) stake by 0.27% in Q2 2026, buying an estimated $5.32K and bringing the position to 4,395 shares worth $2.18M. The position accounts for 2.59% of the portfolio, ranked #13.

Private Harbour Investment Management & Counsel first reported a position in VRTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.5M in Q2 2024. 971 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Private Harbour Investment Management & Counsel held 4,395 shares of Vertex Pharmaceuticals worth $2.18M as of Q2 2026.
  • Private Harbour Investment Management & Counsel bought 12 Vertex Pharmaceuticals shares in Q2 2026, an estimated $5.32K.
  • Vertex Pharmaceuticals made up 2.59% of Private Harbour Investment Management & Counsel's portfolio in Q2 2026, its #13 holding.
  • Private Harbour Investment Management & Counsel first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Private Harbour Investment Management & Counsel's Vertex Pharmaceuticals position peaked at $2.5M in Q2 2024.
  • 971 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Private Harbour Investment Management & Counsel's 13F filing for Q2 2026, filed 4 Aug 2026.